CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
11,506,316
Share change
+1,263,186
Total reported value
$70,874,620
Price per share
$6.16
Number of holders
30
Value change
+$7,921,681
Number of buys
16
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q3 2016

As of 30 Sep 2016, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,506,316 shares. The largest 10 holders included SV Life Sciences Advisers, LLC, Clarus Ventures, LLC, FMR LLC, CAMBER CAPITAL MANAGEMENT LLC, Cormorant Asset Management, LLC, DEERFIELD MANAGEMENT CO, SPHERA FUNDS MANAGEMENT LTD., WELLINGTON MANAGEMENT GROUP LLP, GREAT POINT PARTNERS LLC, and VANGUARD GROUP INC. This page lists 30 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.